Pharmacokinetics of methadone during maintenance therapy: pulse labeling with deuterated methadone in the steady state
- PMID: 499301
- DOI: 10.1007/BF00644967
Pharmacokinetics of methadone during maintenance therapy: pulse labeling with deuterated methadone in the steady state
Abstract
A technique is presented for study of steady state kinetics of methadone using pulse labeling with deuterated methadone (d3) and mass fragmentography to measure both unlabeled and labeled methadone in blood. Seven subjects maintained on methadone for at least 10 months were admitted to a closed metabolic ward. The daily dose of unlabeled methadone (d0) was substituted by one dose of methoadone-d3 and plasma levels of methadone-d0 and methadone-d3 were followed for 48 h using a precise (SD +/- 5%) and sensitive (30 pmol/ml) mass fragmentographic technique. Plasma half-lives (T1/2) for both methadone-do and methadone-d3 were calculated from samples obtained 8--24 H following the dose of methadone-d3. The t1/2 of oral methadone-d3 was shorter (22 +/- 2 h) than that of methadone-d0 (52 +/- 20 h). The same pattern was observed after intravenous administration. The results indicate multiple pools of methadone in the body.
Similar articles
-
Single dose pharmacokinetics and bioavailability of methadone in man studied with a stable isotope method.Eur J Clin Pharmacol. 1981;20(6):473-8. doi: 10.1007/BF00542102. Eur J Clin Pharmacol. 1981. PMID: 7286059
-
Quantitation of methadone enantiomers in humans using stable isotope-labeled [2H3]-, [2H5]-, and [2H8]Methadone.J Pharm Sci. 1982 Jan;71(1):40-3. doi: 10.1002/jps.2600710110. J Pharm Sci. 1982. PMID: 7057377
-
Pharmacokinetics of methadone in methadone maintenance treatment: characterization of therapeutic failures.Eur J Clin Pharmacol. 1983;25(4):497-501. doi: 10.1007/BF00542117. Eur J Clin Pharmacol. 1983. PMID: 6653644
-
Methadone.Can Med Assoc J. 1973 Oct 6;109(7):615-9. Can Med Assoc J. 1973. PMID: 4599599 Free PMC article. Review.
-
The relationship of pharmacokinetics to pharmacological activity: morphine, methadone and naloxone.Clin Pharmacokinet. 1976;1(3):219-30. doi: 10.2165/00003088-197601030-00004. Clin Pharmacokinet. 1976. PMID: 13957 Review.
Cited by
-
Single dose pharmacokinetics and bioavailability of methadone in man studied with a stable isotope method.Eur J Clin Pharmacol. 1981;20(6):473-8. doi: 10.1007/BF00542102. Eur J Clin Pharmacol. 1981. PMID: 7286059
-
Pharmacokinetics of methadone during maintenance treatment: adaptive changes during the induction phase.Eur J Clin Pharmacol. 1982;22(4):343-9. doi: 10.1007/BF00548404. Eur J Clin Pharmacol. 1982. PMID: 7106170
-
Pharmacokinetics of methadone and its primary metabolite in 20 opiate addicts.Eur J Clin Pharmacol. 1995;48(5):361-6. doi: 10.1007/BF00194951. Eur J Clin Pharmacol. 1995. PMID: 8641323
-
Current Concepts in Methadone Metabolism and Transport.Clin Pharmacol Drug Dev. 2017 Mar;6(2):125-134. doi: 10.1002/cpdd.326. Clin Pharmacol Drug Dev. 2017. PMID: 28263461 Free PMC article.
-
Mechanism of autoinduction of methadone N-demethylation in human hepatocytes.Anesth Analg. 2013 Jul;117(1):52-60. doi: 10.1213/ANE.0b013e3182918252. Epub 2013 Jun 3. Anesth Analg. 2013. PMID: 23733841 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources